How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). (Q44739488)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).
scientific article

    Statements

    How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). (English)
    John Wikstrand
    Hans Wedel
    Jalal Ghali
    Prakash Deedwania
    Björn Fagerberg
    Sidney Goldstein
    Stephen Gottlieb
    Ake Hjalmarson
    Finn Waagstein
    1 September 2003
    264-275

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit